dc.contributor.author |
Martac, Ioana |
|
dc.contributor.author |
Beer, Sina A. |
|
dc.contributor.author |
Schenk, Aileen |
|
dc.contributor.author |
Ahmad, Osama |
|
dc.contributor.author |
Maier, Claus-Philipp |
|
dc.contributor.author |
Preuss, Beate |
|
dc.contributor.author |
Klein, Reinhild |
|
dc.contributor.author |
Besemer, Britta |
|
dc.contributor.author |
Hensen, Luca |
|
dc.contributor.author |
Lengerke, Claudia |
|
dc.contributor.author |
Demirel, Gülay |
|
dc.contributor.author |
Stanger, Anna |
|
dc.date.accessioned |
2025-04-29T05:38:47Z |
|
dc.date.available |
2025-04-29T05:38:47Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
1664-3224 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/164762 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Lausanne : Frontiers Media Sa |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.3389/fimmu.2024.1510942 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20250203000000_00099 |
|
utue.personen.roh |
Martac, Ioana |
|
utue.personen.roh |
Beer, Sina A. |
|
utue.personen.roh |
Schenk, Aileen |
|
utue.personen.roh |
Ahmad, Osama |
|
utue.personen.roh |
Maier, Claus-Philipp |
|
utue.personen.roh |
Demirel, Guelay |
|
utue.personen.roh |
Preuss, Beate |
|
utue.personen.roh |
Klein, Reinhild |
|
utue.personen.roh |
Stanger, Anna M. P. |
|
utue.personen.roh |
Besemer, Britta |
|
utue.personen.roh |
Hensen, Luca |
|
utue.personen.roh |
Lengerke, Claudia |
|
dcterms.isPartOf.ZSTitelID |
Frontiers in Immunology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 1510942 |
de_DE |
dcterms.isPartOf.ZS-Volume |
15 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |